Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

ClinicalTrials.gov ID: NCT01619085

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01619085. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 12:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this extension trial is to assess the long-term safety of BIBF 1120 treatment in patients with Idiopathic Pulmonary Fibrosis who have completed one year treatment and the follow up period in the double-blind phase III placebo controlled parent trials (1199.32 and 1199.34), who wish to continue treatment with BIBF 1120.

Study identification

NCT ID
NCT01619085
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
752 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2012 (Actual)
Primary completion
Jul 5, 2017 (Actual)
Completion
Feb 1, 2021 (Actual)
Last update posted
Mar 25, 2022

2012 – 2021

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Jasper Summit Research, LLC Jasper Alabama 35501 —
Pulmonary Associates Phoenix Arizona 85006 —
University of California Los Angeles California 90095-1690 —
University of California San Francisco California 94143 —
Sansum Clinic Santa Barbara California 93105 —
Stanford University Medical Center Stanford California 94305 —
University of California Torrance California 90505 —
Western Connecticut Medical Group Danbury Connecticut 06810 —
Pulmonary Assoc of Stamford Stamford Connecticut 06902 —
Cleveland Clinic Weston Florida 33331 —
Georgia Clinical Research Austell Georgia 30106 —
University of Chicago Chicago Illinois 60637 —
Via Christi Clinic, PA Wichita Kansas 67208 —
Baptist Health Lexington Lexington Kentucky 40503 —
Minnesota Lung Center Minneapolis Minnesota 55407 —
The Lung Research Center, LLC Chesterfield Missouri 63017 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Pulmonary and Critical Care Associates Albany New York 12205 —
Jamaica Hospital Medical Center Jamaica New York 11418 —
New York Presbyterian Hospital New York New York 10032 —
University of Cincinnati Cincinnati Ohio 45267-0565 —
ID Clinical Research, LTD Toledo Ohio 43608 —
The Oregon Clinic Portland Oregon 97220 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37232-5735 —
FDC Seifer PLC Pulmonary Shelbyville Tennessee 37160 —
University of Texas Southwestern Medical Center Dallas Texas 75235-8550 —
DCOL Center for Clinical Research Longview Texas 75605 —
Metroplex Pul and Sleep Ctr McKinney Texas 75069-1769 —
Diagnostics Research Group San Antonio Texas 78229 —
Vermont Lung Center Colchester Vermont 05446 —
Inova Fairfax Hospital Falls Church Virginia 22042 —
Lynchburg Pulmonary Associates Lynchburg Virginia 24501 —
University of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01619085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2022 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.